Despite a recent dip, Haemonetics' robust financials hint at potential long-term stock value growth. High ROE and profit reinvestment suggest promising earnings growth, with analysts predicting continued expansion.
Despite the falling share price, the consistent growth in revenue and EPS could present an investment opportunity if the stock has fallen unfairly. Market expectations may have been unreasonable in the past.
Shareholders appear to hang onto Haemonetics, expecting it to keep beating market trends, due to its projected solid growth. Despite a high P/E, the predicted limited risk of an earnings drop keeps the share price stable.
RDK79
:
Netflix should sue the crap out of Bloomberg! These unsubstantiated postings by financial ‘experts’ without any accountability is amazing. Wall-street is bulletproof
Christina Harrison
:
there is lots of tutorial...most of it useless, hard to find, and term based not so much moo moo app based. mean there is some but its not simple to get to or very user friendly.
Top stocks this week 1.$Pitney Bowes (PBI.US)$- institutional investor left to invest elsewhere is why its down after its 4th ER beat in a row. Pt raised to 11.00 oversold 2.$Casa Systems (CASA.US)$- in about the same boat as PBI. Pt-11.00 oversold 3.$Haemonetics (HAE.US)$way oversold. very little risk of any more backsliding 4.$Clover Health (CLOV.US)$Almost 40% shorted now. Ready to squeeze or make a run at 13.70.
Tom_Jerry
Mcsnacks H Tupack
OP
:
You have projected 13.70 this month. After their latest ER, current is 6.83. Do you expect it will help and move up some this week? Thanks.
Mcsnacks H Tupack
OP
Tom_Jerry
:
Saying this hurt them today. The company also lowered its 2021 revenue projections from $820 to $850 million by the end of the year to $810 to $830 million. PTs were lowered because of that to 9.00. And short sellers doubled down with a million more short shares. Inflation fears aren’t producing much volume in the market either. But shorts will be covering this week. So Wednesday or Thursday after 12 look for a 1-2.00 spike.
Haemonetics Stock Forum
In reaction to earnings/guidance:
• $Gambling.com (GAMB.US)$ +5.5%, $Baidu (BIDU.US)$ +3.6%, $Best Buy (BBY.US)$ +2.4%, $Heico (HEI.US)$ +1.4%, $Big Lots (BIG.US)$ +0.6%
Other news:
• $FREYR Battery (FREY.US)$ +11.4% (announces the execution of 38 GWh Li-Ion Battery binding cell sales agreement; enters into module & pack JV for energy storage solutions with Nidec)
• $Avid Technology (AVID.US)$ +9.6% (to join S&P SmallCap 600)
• $RVL Pharmaceuticals (RVLP.US)$ +2.3% (Re...
In reaction to earnings/guidance:
• $The Trade Desk (TTD.US)$+17%, $Workiva (WK.US)$ +15.3%, $Arlo Technologies (ARLO.US)$ +12%, $Array Technologies (ARRY.US)$ +10.3%, $Everbridge (EVBG.US)$ +9.7%, $Catalyst Pharmaceuticals (CPRX.US)$ +9.4%, $Halozyme Therapeutics (HALO.US)$ +8.7%, $Velo3D (VLD.US)$ +7.6%, $CyberArk (CYBR.US)$ + 6.2%, $Haemonetics (HAE.US)$ +5.8%, $Jackson Financial (JXN.US)$ +5.7% (also increases dividend), $Axon Enterprise (AXON.US)$ +4.8%, ...
1. $Pitney Bowes (PBI.US)$ - institutional investor left to invest elsewhere is why its down after its 4th ER beat in a row. Pt raised to 11.00 oversold
2. $Casa Systems (CASA.US)$- in about the same boat as PBI. Pt-11.00 oversold
3. $Haemonetics (HAE.US)$ way oversold. very little risk of any more backsliding
4. $Clover Health (CLOV.US)$ Almost 40% shorted now. Ready to squeeze or make a run at 13.70.
No comment yet